查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1679220

2030 年医用聚合物市场预测：按产品类型、製造流程、应用和地区进行的全球分析

Medical Polymers Market Forecasts to 2030 - Global Analysis By Product Type (Biodegradable Polymers and Non-Biodegradable Polymers), Manufacturing Process, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球医用聚合物市场预计在 2024 年达到 413 亿美元，到 2030 年将达到 682 亿美元，预测期内的复合年增长率为 8.7%。

医用聚合物是用于药物输送系统、包装、植入和医疗设备的专用材料。这些聚合物具有耐用性、灵活性和生物相容性。其中包括硅胶、聚乙烯、聚丙烯和生物分解性。它对于手术器械、义肢、导管和药品包装的製造至关重要。它们的轻量化设计、耐化学性和无菌性对现代医学至关重要，因为它们可确保各种医疗应用中的患者安全、疗效和更好的结果。

根据PMC的研究，美国消耗了全球製造的约40%的医疗设备，其次是欧洲和日本。

医疗设备和植入需求不断成长

慢性病的增加和人口老化正在推动医疗设备和植入产业的显着成长。对先进医疗工具、仪器和植入的需求激增直接推动了医用聚合物市场的发展。先进的聚合物技术使得创造出尖端的医疗设备成为可能，这些设备可确保生物相容性、弹性以及在医疗环境中易于消毒的程序，使其成为现代医疗保健服务中必不可少的。

原料成本上涨

医用聚合物製造成本的上升对市场成长构成了重大挑战。製造过程需要专门的设备、熟练的劳动力和大量的能源投入，而原材料往往稀缺且昂贵。它们的生产成本比传统聚合物高达五倍，这使得它们在许多应用领域中经济上难以承受，也限制了它们在成本敏感领域的广泛使用。

扩大药物传输应用

生物製药和个人化医疗的发展为基于聚合物的药物输送系统创造了重大机会。先进的聚合物配方能够控制和延长药物的释放，从而提高治疗效果和患者依从性。 3D 列印和奈米技术等新技术的融合，使得药物配方更加精确、可客製化，刺激了研发投资。

产品责任及召回风险

对医疗设备原始设计的任何更改或补充都会使召回风险增加约 30%。基于聚合物的医疗设备非常复杂，且受到严格的监管要求，因此存在巨大的责任风险。最近的研究表明某些聚合物对健康有不利影响，引发了安全担忧，这可能会影响市场成长并要求製造商保持严格的品管措施。

COVID-19 的影响：

COVID-19 疫情对医用聚合物市场产生了积极影响，主要是由于对疫苗接种用一次性注射器的需求增加。製药业的繁荣透过增加对药品包装的要求，为市场的成长做出了巨大的贡献。全球感染疾病威胁凸显了医用聚合物在医疗保健应用中的重要性，加速了市场扩张。

预测期内，非生物分解聚合物市场预计将成为最大的市场

由于其优异的耐用性、耐化学性和成熟的製造工艺，预计非生物分解聚合物将在预测期内占据最大的市场占有率。这些材料广泛应用于长期医疗设备、手术器械和医疗包装应用。这种可靠性，加上在关键医疗应用中经过验证的性能，使其成为医疗保健提供者和医疗设备製造商的首选，确保了其持续的市场主导。

预计组织工程和再生医学领域将在预测期内见证最高的复合年增长率。

由于技术进步和生物技术投资的增加，组织工程和再生医学领域预计将在预测期内见证最高成长率。用于组织再生的创新聚合物支架和基质的开发为再生医学开闢了新的可能性。研究活动的活性化和对先进治疗解决方案的需求不断增长进一步支持了这一领域的扩张。

占比最大的地区：

在预测期内，北美预计将占据最大的市场占有率，这得益于广泛的医疗保健基础设施和先进医疗技术的高度采用。平价医疗法案和医疗补助等政府关键倡议增强了该地区的优势，扩大了医疗保健的机会并增加了对医疗设备和药品包装的需求。

复合年增长率最高的地区：

在预测期内，由于医疗保健行业的快速扩张和医疗旅游业的兴起，预计亚太地区将呈现最高的复合年增长率。泰国、新加坡和印度等国家正成为主要的医疗旅游目的地，刺激了对先进医疗设备和植入的需求。政府措施和不断增加的医疗支出进一步支持了该地区的成长。

免费客製化服务：

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他市场公司（最多 3 家公司）进行全面分析
    • 主要企业的 SWOT 分析（最多 3 家公司）
  • 地理细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争性基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二手研究资料资讯来源
    • 先决条件

第三章 市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 新兴市场
  • COVID-19 的影响

第 4 章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球医用聚合物市场（依产品类型）

  • 生物分解性聚合物
    • 聚乳酸（PLA）
    • 聚羟基烷酯(PHA)
    • 其他生物分解性聚合物
  • 非生物分解的聚合物
    • 通用聚合物
      • 聚丙烯（PP）
      • 聚乙烯 (PE)
      • 聚氯乙烯（PVC）
      • 聚苯乙烯（PS）
    • 工程树脂
      • 聚氨酯 (PU)
      • 聚甲基丙烯酸甲酯 (PMMA)
      • 聚碳酸酯（PC）
      • 其他工程树脂
    • 医用合成橡胶
      • 热可塑性橡胶(TPE)
      • 硅橡胶
      • 苯乙烯嵌段共聚物
    • 高性能聚合物
      • PEEK（聚醚醚酮）
      • PEI（聚醚酰亚胺）
      • PPSU（聚苯砜）
      • 液晶聚合物（LCP）

6. 全球医用聚合物市场依製造流程划分

  • 初级处理
    • 射出成型
    • 挤压
    • 压缩成型
    • 吹塑成型
    • 铸件
  • 进阶处理
    • 3D 列印
    • 热成型
    • 表面处理
    • 连接技术

7. 全球医用聚合物市场（按应用）

  • 医疗一次性用品
  • 医疗设备
  • 药物输送系统
  • 义肢和矫正器具
  • 组织工程与再生医学
  • 诊断设备和工具
  • 医疗包装

8. 全球医用聚合物市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第九章 主要进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司概况

  • Medtronic PLC
  • Johnson & Johnson
  • DowDuPont
  • BASF SE
  • Evonik Industries AG
  • Covestro AG
  • Asahi Kasei Corporation
  • DSM
  • Mitsubishi Chemical Corporation
  • Lubrizol Corporation
  • SABIC
  • Solvay SA
  • Arkema SA
  • Celanese Corporation
  • Eastman Chemical Company
  • Kraton Corporation
  • Tekni-Plex, Inc.
  • Victrex plc
Product Code: SMRC28803

According to Stratistics MRC, the Global Medical Polymers Market is accounted for $41.3 billion in 2024 and is expected to reach $68.2 billion by 2030 growing at a CAGR of 8.7% during the forecast period. Medical polymers are specialty materials utilized in drug delivery systems, packaging, implants, and medical equipment. These polymers provide durability, flexibility, and biocompatibility. They include silicone, polyethylene, polypropylene, and biodegradable varieties. They are essential to the production of surgical equipment, prosthesis, catheters, and pharmaceutical packaging. They are crucial to modern medicine because of their lightweight design, chemical resistance, and sterilizability, which guarantee patient safety, effectiveness, and better results in a range of medical applications.

According to PMC studies, the US consumes around 40% of medical devices manufactured globally, followed by Europe and Japan.

Market Dynamics:

Driver:

Rising demand for medical devices and implants

The increasing prevalence of chronic diseases and aging population is driving substantial growth in the medical devices and implants sector. The surge in demand for sophisticated medical tools, apparatus, and implants has directly boosted the medical polymers market. Advanced polymer technology has enabled the creation of cutting-edge medical devices that ensure biocompatibility, resilience, and straightforward sterilization procedures in medical environments, making them essential for modern healthcare delivery.

Restraint:

High cost of raw materials

The elevated production costs of medical polymers pose significant challenges to market growth. The manufacturing processes require specialized equipment, skilled labor, and considerable energy input, while raw materials are often rare and expensive. The production costs can be up to five times higher than conventional polymers, making them economically challenging for many applications and limiting widespread adoption across cost-sensitive sectors.

Opportunity:

Expanding applications in drug delivery

The growth in biopharmaceuticals and personalized medicine has created significant opportunities for polymer-based drug delivery systems. Advanced polymeric formulations enable controlled and prolonged release of medications, enhancing treatment efficacy and patient adherence. The integration of novel technologies like 3D printing and nanotechnology is improving the precision and customization of drug formulations, driving investment in research and development.

Threat:

Product liability and recall risks

Medical devices face approximately 30% increased risk of recalls following modifications and supplements to their original design. The complexity of polymer-based medical devices and stringent regulatory requirements create significant liability risks. Recent studies linking certain polymers to adverse health effects have raised safety concerns, potentially impacting market growth and requiring manufacturers to maintain rigorous quality control measures.

Covid-19 Impact:

The Covid-19 pandemic had a positive impact on the medical polymers market, primarily driven by increased demand for single-use syringes for vaccinations. The thriving pharmaceutical industry contributed significantly to market growth through elevated requirements for medication packaging. The global threat of infectious diseases highlighted the importance of medical polymers in healthcare applications, accelerating market expansion.

The non-biodegradable polymers segment is expected to be the largest during the forecast period

The non-biodegradable polymers segment is expected to account for the largest market share during the forecast period due to their superior durability, chemical resistance, and established manufacturing processes. These materials are extensively used in long-term medical devices, surgical instruments, and medical packaging applications. Their reliability, coupled with proven performance in critical medical applications, has made them the preferred choice for healthcare providers and medical device manufacturers, ensuring their continued market leadership.

The tissue engineering & regenerative medicine segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the tissue engineering & regenerative medicine segment is predicted to witness the highest growth rate due to technological advancements and increasing investment in biotechnology. The development of innovative polymer-based scaffolds and matrices for tissue regeneration has opened new possibilities in regenerative medicine. This segment's expansion is further supported by growing research activities and the rising demand for advanced healing solutions.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share driven by extensive healthcare infrastructure and high adoption of advanced medical technologies. The region's dominance is reinforced by significant government initiatives like the Affordable Care Act and Medicaid, which have expanded healthcare access and increased demand for medical devices and pharmaceutical packaging.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by rapid healthcare sector expansion and increasing medical tourism. Countries like Thailand, Singapore, and India are emerging as major medical tourism destinations, fueling demand for sophisticated medical devices and implants. The region's growth is further supported by government initiatives and increasing healthcare expenditure.

Key players in the market

Some of the key players in Medical Polymers Market include Medtronic PLC, Johnson & Johnson, DowDuPont, BASF SE, Evonik Industries AG, Covestro AG, Asahi Kasei Corporation, DSM, Mitsubishi Chemical Corporation, Lubrizol Corporation, SABIC, Solvay S.A., Arkema S.A., Celanese Corporation, Eastman Chemical Company, Kraton Corporation, Tekni-Plex, Inc. and Victrex plc.

Key Developments:

In October 2024, The Japanese technology company Asahi Kasei signed a memorandum of understanding (MOU) with Aquafil S.p.A., an Italian manufacturer of polyamide 6 (PA6). The two companies agreed to develop a novel material for 3D printing (3DP) applications utilizing Aquafil's ECONYL(R) Polymer chemically recycled PA6 and Asahi Kasei's cellulose nanofiber (CNF), with the support of ITOCHU Corporation, which has made a capital investment in Aquafil. Pellets or filaments of this compound achieve superior formability and strength, which make them suitable for use in automotive and aeronautical applications.

In September 2024, Evonik has officially opened a new facility for drying aqueous dispersions of EUDRAGIT(R) polymers at its site in Darmstadt. The new double-digit million-euro excipient manufacturing facility enables Evonik to meet the increasing demand from pharmaceutical customers for oral drug delivery solutions. By expanding production capacities, Evonik is improving supply security and shortening delivery times for EUDRAGIT(R) polymers. The new plant also operates using green electricity and steam generated from local waste incineration, saving more than 1,000 tons of CO2 equivalents per year.

In October 2023, BASF changed its European direct business for Ultraform(R) (POM) and transfer the sales process to its long-standing trusted trading partners, ALBIS and Ultrapolymers Group. Ultraform(R) is and will remain an important part of BASF's engineering plastics portfolio. By maintaining research and development for Ultraform(R) within BASF, customers will continue to benefit from BASF's innovations and broad expertise, especially in solving technical challenges.

Product Types Covered:

  • Biodegradable Polymers
  • Non-biodegradable Polymers

Manufacturing Process Covered:

  • Primary Processing
  • Advanced Processing

Applications Covered:

  • Medical Disposables
  • Medical Devices & Equipment
  • Drug Delivery Systems
  • Prosthetics & Orthotics
  • Tissue Engineering & Regenerative Medicine
  • Diagnostic Instruments & Tools
  • Medical Packaging

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Medical Polymers Market, By Product Type

  • 5.1 Introduction
  • 5.2 Biodegradable Polymers
    • 5.2.1 Polylactic Acid (PLA)
    • 5.2.2 Polyhydroxyalkanoates (PHA)
    • 5.2.3 Other Biodegradable Polymers
  • 5.3 Non-biodegradable Polymers
    • 5.3.1 Commodity Polymers
      • 5.3.1.1 Polypropylene (PP)
      • 5.3.1.2 Polyethylene (PE)
      • 5.3.1.3 Polyvinyl Chloride (PVC)
      • 5.3.1.4 Polystyrene (PS)
    • 5.3.2 Engineering Resins
      • 5.3.2.1 Polyurethane (PU)
      • 5.3.2.2 Polymethyl Methacrylate (PMMA)
      • 5.3.2.3 Polycarbonate (PC)
      • 5.3.2.4 Other Engineering Resins
    • 5.3.3 Medical Elastomers
      • 5.3.3.1 Thermoplastic Elastomers (TPE)
      • 5.3.3.2 Silicone Elastomers
      • 5.3.3.3 Styrenic Block Copolymers
    • 5.3.4 High-Performance Polymers
      • 5.3.4.1 PEEK (Polyether Ether Ketone)
      • 5.3.4.2 PEI (Polyetherimide)
      • 5.3.4.3 PPSU (Polyphenylsulfone)
      • 5.3.4.4 Liquid Crystal Polymers (LCPs)

6 Global Medical Polymers Market, By Manufacturing Process

  • 6.1 Introduction
  • 6.2 Primary Processing
    • 6.2.1 Injection Molding
    • 6.2.2 Extrusion
    • 6.2.3 Compression Molding
    • 6.2.4 Blow Molding
    • 6.2.5 Cast Molding
  • 6.3 Advanced Processing
    • 6.3.1 3D Printing
    • 6.3.2 Thermoforming
    • 6.3.3 Surface Treatment
    • 6.3.4 Joining Techniques

7 Global Medical Polymers Market, By Application

  • 7.1 Introduction
  • 7.2 Medical Disposables
  • 7.3 Medical Devices & Equipment
  • 7.4 Drug Delivery Systems
  • 7.5 Prosthetics & Orthotics
  • 7.6 Tissue Engineering & Regenerative Medicine
  • 7.7 Diagnostic Instruments & Tools
  • 7.8 Medical Packaging

8 Global Medical Polymers Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Medtronic PLC
  • 10.2 Johnson & Johnson
  • 10.3 DowDuPont
  • 10.4 BASF SE
  • 10.5 Evonik Industries AG
  • 10.6 Covestro AG
  • 10.7 Asahi Kasei Corporation
  • 10.8 DSM
  • 10.9 Mitsubishi Chemical Corporation
  • 10.10 Lubrizol Corporation
  • 10.11 SABIC
  • 10.12 Solvay S.A.
  • 10.13 Arkema S.A.
  • 10.14 Celanese Corporation
  • 10.15 Eastman Chemical Company
  • 10.16 Kraton Corporation
  • 10.17 Tekni-Plex, Inc.
  • 10.18 Victrex plc

List of Tables

  • Table 1 Global Medical Polymers Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Medical Polymers Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Medical Polymers Market Outlook, By Biodegradable Polymers (2022-2030) ($MN)
  • Table 4 Global Medical Polymers Market Outlook, By Polylactic Acid (PLA) (2022-2030) ($MN)
  • Table 5 Global Medical Polymers Market Outlook, By Polyhydroxyalkanoates (PHA) (2022-2030) ($MN)
  • Table 6 Global Medical Polymers Market Outlook, By Other Biodegradable Polymers (2022-2030) ($MN)
  • Table 7 Global Medical Polymers Market Outlook, By Non-biodegradable Polymers (2022-2030) ($MN)
  • Table 8 Global Medical Polymers Market Outlook, By Commodity Polymers (2022-2030) ($MN)
  • Table 9 Global Medical Polymers Market Outlook, By Engineering Resins (2022-2030) ($MN)
  • Table 10 Global Medical Polymers Market Outlook, By Medical Elastomers (2022-2030) ($MN)
  • Table 11 Global Medical Polymers Market Outlook, By High-Performance Polymers (2022-2030) ($MN)
  • Table 12 Global Medical Polymers Market Outlook, By Manufacturing Process (2022-2030) ($MN)
  • Table 13 Global Medical Polymers Market Outlook, By Primary Processing (2022-2030) ($MN)
  • Table 14 Global Medical Polymers Market Outlook, By Injection Molding (2022-2030) ($MN)
  • Table 15 Global Medical Polymers Market Outlook, By Extrusion (2022-2030) ($MN)
  • Table 16 Global Medical Polymers Market Outlook, By Compression Molding (2022-2030) ($MN)
  • Table 17 Global Medical Polymers Market Outlook, By Blow Molding (2022-2030) ($MN)
  • Table 18 Global Medical Polymers Market Outlook, By Cast Molding (2022-2030) ($MN)
  • Table 19 Global Medical Polymers Market Outlook, By Advanced Processing (2022-2030) ($MN)
  • Table 20 Global Medical Polymers Market Outlook, By 3D Printing (2022-2030) ($MN)
  • Table 21 Global Medical Polymers Market Outlook, By Thermoforming (2022-2030) ($MN)
  • Table 22 Global Medical Polymers Market Outlook, By Surface Treatment (2022-2030) ($MN)
  • Table 23 Global Medical Polymers Market Outlook, By Joining Techniques (2022-2030) ($MN)
  • Table 24 Global Medical Polymers Market Outlook, By Application (2022-2030) ($MN)
  • Table 25 Global Medical Polymers Market Outlook, By Medical Disposables (2022-2030) ($MN)
  • Table 26 Global Medical Polymers Market Outlook, By Medical Devices & Equipment (2022-2030) ($MN)
  • Table 27 Global Medical Polymers Market Outlook, By Drug Delivery Systems (2022-2030) ($MN)
  • Table 28 Global Medical Polymers Market Outlook, By Prosthetics & Orthotics (2022-2030) ($MN)
  • Table 29 Global Medical Polymers Market Outlook, By Tissue Engineering & Regenerative Medicine (2022-2030) ($MN)
  • Table 30 Global Medical Polymers Market Outlook, By Diagnostic Instruments & Tools (2022-2030) ($MN)
  • Table 31 Global Medical Polymers Market Outlook, By Medical Packaging (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.